semaglutide dissolvable tablets Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment contain semaglutide Semaglutide + B6 & B12

TM30338, a dual Y 2 -Y 4 receptor agonist that leads to an acute reduction in food intake, and TM30339, a selective Y 4 receptor agonist, which is likely to be the subject of phase I/II study in the near future

Assessment of sleep duration and cortisol levels among selected South African medical students

Improve blood sugar control: Making it beneficial for individuals with diabetes

Ideal for private label, white label products, and professional skincare collections, this peptide-powered serum delivers visible results for anyone seeking firmer, healthier, more radiant skin

Treatment with licogliflozin (150 mg for 12 weeks) resulted in significant improvement in serum ALT levels in patients with MASH (NCT03205150)